{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zimbalist AS"],"funding":["American Institute for Cancer Research","NCI NIH HHS","National Cancer Institute, United States"],"pagination":["1361"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9801571"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["22(1)"],"pubmed_abstract":["Research on the impact of metabolic abnormalities on breast cancer prognosis is limited by small samples and assessment of laboratory values at a single time point, often prior to cancer diagnosis and treatment. In this population-based cohort, time-updated laboratory values were adjusted for cancer treatment to assess the association between metabolic risk factors (glucose, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides) and breast cancer survival. 13,434 women diagnosed with stage I-III breast cancer from 2005-15 at Kaiser Permanente were included. All outpatient fasting glucose, HDL-C, LDL-C, and triglyceride values from diagnosis through 2019 or death were extracted from electronic medical records. Risk of breast cancer-specific"],"journal":["BMC cancer"],"pubmed_title":["Metabolic abnormalities and survival among patients with non-metastatic breast cancer."],"pmcid":["PMC9801571"],"funding_grant_id":["632996","R01 CA251589","R01CA251589"],"pubmed_authors":["Dillon DAR","Zimbalist AS","Mittendorf EA","Quesenberry C","Cespedes Feliciano EM","Caan BJ","Chen WY"],"additional_accession":[]},"is_claimable":false,"name":"Metabolic abnormalities and survival among patients with non-metastatic breast cancer.","description":"Research on the impact of metabolic abnormalities on breast cancer prognosis is limited by small samples and assessment of laboratory values at a single time point, often prior to cancer diagnosis and treatment. In this population-based cohort, time-updated laboratory values were adjusted for cancer treatment to assess the association between metabolic risk factors (glucose, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides) and breast cancer survival. 13,434 women diagnosed with stage I-III breast cancer from 2005-15 at Kaiser Permanente were included. All outpatient fasting glucose, HDL-C, LDL-C, and triglyceride values from diagnosis through 2019 or death were extracted from electronic medical records. Risk of breast cancer-specific","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-05-29T16:21:57.776Z","creation":"2025-04-19T18:09:34.067Z"},"accession":"S-EPMC9801571","cross_references":{"pubmed":["36581817"],"doi":["10.1186/s12885-022-10430-9"]}}